SCHEMBL5011070

SCHEMBL5011070

CN1C(=O)CC(c2ccc(C(N)=O)c(N3CCC(C)(C)CC3)c2)CC1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 2/20 0.37
CDK9 P50750 1/20 0.37
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
THRB P10828 1/20 0.36
ALOX15 P16050 1/20 0.36
GFER P55789 1/20 0.36
YWHAG P61981 1/20 0.36
KMT2A Q03164 1/20 0.36
HSD17B10 Q99714 1/20 0.36
HTT P42858 1/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
HSP90AA1 P07900 7/20 0.34
HSP90AB1 P08238 4/20 0.34
PDE4A P27815 2/20 0.33
PDE4B Q07343 2/20 0.33
PDE4C Q08493 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5012415 0.85 CDC7 (0.36) CDC7CDK9KDM4EMEN1MAPT
SCHEMBL5011082 0.84 GAA (0.38) KDM4EMEN1MAPTTHRBALOX15
SCHEMBL5009206 0.82 CDC7 (0.36) CDC7CDK9KDM4EMEN1MAPT
SCHEMBL31038511 0.74 ALDH1A1 (0.59) MEN1MAPTKMT2AHTTALDH1A1
SCHEMBL5006300 0.74 KIF18A (0.38) CDC7CDK9KDM4EMEN1MAPT
SCHEMBL5009210 0.73 HTT (0.50) CDC7CDK9KDM4EMEN1MAPT
SCHEMBL5006255 0.73 ALDH1A1 (0.47) CDC7CDK9KDM4EMEN1MAPT
SCHEMBL1858955 0.71 CSF1R (0.61)
SCHEMBL12381966 0.70 CSF1R (0.44) HSD17B10NPC1IRAK4
SCHEMBL5006309 0.70 ALDH1A1 (0.46) CDC7CDK9KDM4EMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9296726-B2 Inhibitors of c-fms kinase JANSSEN PHARMACEUTICA NV (BE) 2016-03-29 US disclosed
US-20150051196-A1 INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2015-02-19 US disclosed
US-8895584-B2 Inhibitors of c-fms kinase JANSSEN PHARMACEUTICA NV (BE) 2014-11-25 US disclosed
US-20140243382-A1 INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2014-08-28 US disclosed
US-8759347-B2 Inhibitors of C-FMS kinase JANSSEN PHARMACEUTICA NV (BE) 2014-06-24 US disclosed
US-20130281475-A1 INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2013-10-24 US disclosed
US-8481564-B2 Inhibitors of c-fms kinase JANSSEN PHARMACEUTICA, N.V. (BE) 2013-07-09 US disclosed
US-20080275031-A1 4-Cyano-1H-imidazole-2-carboxylic acid [2-cyclohex-1-enyl-4-(2,6-dioxo-piperidin-4-yl)-phenyl]-amide; tyrosine kinase inhibitor; autoimmune diseases, antiinflammatory, anticarcinogenic agent ILLIG CARL R 2008-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130281475-A1 INHIBITORS OF C-FMS KINASE MUSK, FRK, FES CDC7 814/4885CDK9 228/4885KDM4E 1770/4885
US-20150051196-A1 INHIBITORS OF C-FMS KINASE MUSK, FRK, FES CDC7 814/4885CDK9 228/4885KDM4E 1770/4885
US-20140243382-A1 INHIBITORS OF C-FMS KINASE MUSK, FRK, FES CDC7 814/4885CDK9 228/4885KDM4E 1770/4885
US-20080275031-A1 4-Cyano-1H-imidazole-2-carboxylic acid [2-cyclohex-1-enyl-4-(2,6-dioxo-piperidin-4-yl)-phenyl]-amide; tyrosine kinase inhibitor; autoimmune diseases, antiinflammatory, anticarcinogenic agent MUSK, CHUK, CAMK4 CDC7 704/4885CDK9 162/4885KDM4E 1708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.